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Polycomb complexes (PRC1 and PRC2) are essential
regulators of epigenetic gene silencing in embryonic
and adult stem cells. Emerging evidence suggests
that the core subunit composition regulates distinct
biological processes, yet little is known about
the mechanistic underpinnings of how differently
composed Polycomb complexes instruct and main-
tain cell fate. Here we find that Mel18, also known
as Pcgf2 and one of six Pcgf paralogs, uniquely reg-
ulates PRC1 to specify mesoderm cell fate in embry-
onic stem cells. Mechanistically, Mel18 functions as
a classical Polycomb protein during early cardiac
mesoderm differentiation by repressing pluripo-
tency, lineage specification, late cardiac differentia-
tion, and negative regulators of the BMP pathway.
However, Mel18 also positively regulates expression
of key mesoderm transcription factors, revealing an
unexpected function of Mel18 in gene activation
during cardiac differentiation. Taken together, our
findings reveal that Mel18 is required to specify
PRC1 function in both a context- and stage-specific
manner.
INTRODUCTION
The Polycomb group of complexes (PcG) are implicated in
development, cancer, and stem cell fate decisions (Di Croce
and Helin, 2013). They are classified as two main complexes,
the Polycomb repressive complexes 1 (PRC1) and 2 (PRC2)
(Morey and Helin, 2010). PRC2 comprises three core subunits:
Eed, Suz12, and the histone methyltransferases Ezh1/2, which
deposit di- and tri-methylation on lysine 27 of the histone H3
(H3K27me2/3) (Cao et al., 2002). PRC1 contains the E3 ligases
Ring1A/B, which monoubiquitinate lysine 119 at histone H2A
(H2AK119ub) (Wang et al., 2004). PRC1 complexes can be300 Cell Stem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Ifurther distinguished based on their subunit composition as
canonical PRC1 (cPRC1), which contains Cbx proteins, or non-
canonical PRC1 (ncPRC1), which lacks Cbx proteins. The high
level of heterogeneity in the architecture of different PRC1 com-
plexes suggests that their specific gene targets, recruitment
mechanisms, and enzymatic activities are context specific.
Consistently, we and others have shown that cPRC1 complexes
interchange Cbx7 in pluripotent embryonic stem cells (ESCs) for
Cbx2 and Cbx4 in differentiating ESCs (Morey et al., 2012;
O’Loghlen et al., 2012).
Although Polycomb activity is mainly associated with gene
repression, Polycomb complexes can also bind to active pro-
moters, where they regulate gene expression positively (Creppe
et al., 2014; Frangini et al., 2013; Schaaf et al., 2013; Suzuki et al.,
2002). Further, in MEF cells, depleting the non-coding RNA
(ncRNA) lincRNA-p21 upregulated a subset of PRC2 targets,
although H3K27me3 remained unaffected in these promoters
(and the presence of Cbx was not investigated) (Dimitrova
et al., 2014). It thus seems plausible that certain genes contain-
ing Cbx proteins and H3K27me3 are expressed in specific
cellular processes.
PRC1 heterogeneity is further defined by the six Polycomb-
group RING finger protein (Pcgf) paralogs (Gao et al., 2012).
Pcgf2/Mel18 (referred to herein as Mel18) and Pcgf4/Bmi1
enhance Ring1B-mediated enzymatic activity in vitro through a
direct interaction of their RING domains (Buchwald et al., 2006;
Elderkin et al., 2007; Li et al., 2006). Pcgf4/Bmi1 expression is
strongly upregulated during neuronal differentiation and is
essential for neuroprecursor (NPC) maintenance and hemato-
poietic stem cell (HSC) self-renewal (Bruggeman et al., 2005;
Oguro et al., 2010; Smith et al., 2011; Zencak et al., 2005).
Pcgf1/NSPc1, together with the transcription factor Runx1,
also regulate HSC differentiation and self-renewal (Ross et al.,
2012). Although it is well established that Polycomb complexes
are essential regulators of ESC differentiation in vitro (Laugesen
and Helin, 2014), very little is known about the functions of
Pcgf proteins in this context. Mel18, Pcgf1, and Pcgf6 are highly
expressed core subunits of different PRC1 complexes in
ESCs, suggesting that they, similar to the Cbx proteins, can
functionally define PRC1 activities. Indeed, Pcgf6 was recentlync.
demonstrated to be functionally essential for ESC self-renewal
(Zdzieblo et al., 2014). PRC1 activities and functions have been
extensively studied mainly in the context of Ring1A/B depletion,
but PRC1 heterogeneity—in both complex composition and ac-
tivity—now suggests that specific PRC1 complexes have unique
functions during development and stem cell differentiation.
To date, no PRC1members have been described to be impor-
tant for in vivo or in vitro cardiac development and differentiation,
yet the PRC2 core subunit Ezh2 has been described to be essen-
tial for cardiomyocyte (CM) proliferation, survival, and postnatal
cardiac homeostasis (Delgado-Olguı´n et al., 2012), and Eed and
Jarid2 are required for heart formation (Laugesen and Helin,
2014). Mel18 is not essential during embryogenesis, but mutant
mice have growth deficiencies, homeotic transformations, and
hematopoietic defects and die a few days or weeks after birth
(Akasaka et al., 2001). Skeletal and hematopoietic tissues derive
from the mesoderm lineages, suggesting that Mel18 could
specialize during development.
Here, we have characterized the function of Mel18 in ESC plu-
ripotency and differentiation. We show that Mel18 binds to
cPRC1 target genes in ESCs and that it is essential for stabilizing
cPRC1 and for cPRC1-mediated gene repression. Using direct
differentiation assays of ESCs to CMs, cartilage, and NPCs,
we elucidate a specific function of Mel18 during the early stages
ofmesoderm differentiation. Mechanistically, we found that, dur-
ing cardiac differentiation, the Mel18-PRC1 complex not only re-
presses pluripotency genes, BMP-negative regulators, and cell
fate identity genes, but also facilitates transcription of transcrip-
tion factors that are essential for differentiation of early cardiac-
mesoderm precursor cells (MES cells).
RESULTS
Mel18 Binds to cPRC1 Target Genes, Regulates
Transcription, and Stabilizes the cPRC1 Complex Only
in ESCs
Mel18 is extensively considered to be an integral subunit of
cPRC1 in ESCs (Luis et al., 2012), yet no genome-wide studies
of Mel18 binding to chromatin have been reported to date. We
thus performed Mel18 chromatin immunoprecipitation (ChIP)
experiments with massive-parallel sequencing (ChIP-seq). We
identified 6,593 peaks, resulting in 4,162 target genes (Figure 1A;
Table S1). Heat maps of Mel18 ChIP-seq signals revealed that all
Mel18 targets are also co-occupied by Ring1B andCbx7 and are
decorated with H2AK119ub (Figure 1A). Further analyses of
Mel18, Ring1B, Cbx7, and H2AK119ub ChIP-seq signals at the
4,162 Mel18 target genes corroborated that Mel18 targets are
PRC1 target genes (Figures 1B and 1C). These results further
highlight that Mel18 occupancy is always within the context of
the PRC1 complex.
To determine whether Mel18 is necessary for both ESC self-
renewal and cPRC1 stability, we depleted Mel18 using two spe-
cific shRNAs (Figure S1A). Analysis of the pluripotency markers
and alkaline phosphatase (AP) staining of control and Mel18
knockdown (KD) cells suggested that Mel18 is not required for
ESC self-renewal (Figures S1B–S1E). Western blots of control
and Mel18 KD extracts suggested that Mel18 is required for sta-
bility of Phc1 and Cbx7 proteins (Figure 1D). Pcgf proteins
directly interact with Phc proteins through their RAWUL domainsCell S(Junco et al., 2013) and with Ring1B through their RING domains
(Li et al., 2006). However, as Pcgf proteins do not directly interact
with Cbx proteins, the reduced levels of Cbx7 in Mel18-depleted
cells suggested thatMel18 is required for cPRC1 complex stabil-
ity (Figure 1D). Moreover, endogenous co-immunoprecipitation
(coIP) experiments using a Ring1B antibody indicated that
cPRC1was strongly destabilized, as Phc1 andCbx7 interactions
were significantly reducedwhenMel18was depleted (Figure 1D).
As expected, the Rybp-Ring1B interaction was not affected.
We conclude that Mel18 depletion specifically disrupted the
cPRC1 complex in ESCs, while the ncPRC1 complex remained
unaffected.
We then asked whether Ring1B, Cbx7, and PRC2 binding to
chromatin was affected in Mel18 KD cells. ChIP-qPCR experi-
ments indicated that Cbx7 and Ring1B recruitment was strongly
reduced in shMel18 cells (Figure 1E), concomitant with a slight
reduction of H2AK119ub levels (Figure S1F, left panel) and
Suz12 occupancy (Figure S1F, right panel). As Cbx7 is required
for efficient binding to chromatin of Ring1B, Mel18, and PRC2
(Morey et al., 2012), we cannot exclude the possibility that the
reduced occupancy of Ring1B in Mel18 KD cells stemmed from
reduced Cbx7 protein levels. Although we observed a 25%
reduction of H2AK119ub levels and Suz12 binding in Mel18-
depleted ESCs (Figure S1F, left panel), global H2AK119ub and
H3K27me3 levels remained unaffected (Figure S1G).
We observed that reduced occupancy of cPRC1 resulted in
gene de-repression (Figure S1H). RNA-seq experiments (Table
S1) revealed that in shMel18 ESCs, 868 genes were deregulated
(with 720 upregulated and 148 downregulated) (Figure 1F, left
panel). As anticipated, Ring1B mutant cells have a major impact
on gene deregulation (Figure 1F, right panel). Importantly, almost
50%of the upregulated genes inMel18 KD cells areMel18 target
genes, and from those, 95% are co-bound by Ring1B (Fig-
ure 1G). This result is consistent with our Mel18 ChIP-seq
analysis, in which all Mel18 target genes were also Ring1B tar-
gets, and also denotes that Mel18 is important for maintaining
gene repression. Gene ontology (GO) analysis of upregulated
Mel18 target genes scored them as being strongly associated
to mesoderm genes, and to a lesser extent, as ectoderm genes,
suggesting a particular role for Mel18 in mesoderm cell fate
(Figure 1H).
Mel18 Is Necessary for Proper Cardiac Differentiation of
Embryoid Bodies
We next asked whether Mel18 is essential for ESC differentia-
tion. We first generated embryoid bodies (EBs) from control
and Mel18 KD ESCs. EBs mimic early development of the em-
bryo and are often used as a differentiation assay to test ESC
pluripotency (Evans and Kaufman, 1981). AP staining of EBs at
day 7 showed that more than double the amount of colonies
appeared to be AP+ in the shMel18 ESCs as compared to the
control ESCs (Figure S2A), suggesting that a lack of Mel18
impairs proper differentiation. We then generated 12-day-old
EBs, which have cells from all three germ layers. From days
2–10, shMel18 EBs were macroscopically very similar to control
EBs; however, at day 12, they exhibited an irregular internal
bulk and did not present any sign of beating, which is usually
observed from day 10 in normal EBs (Figure 2A and data
not shown). Although pluripotency genes were efficientlytem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Inc. 301
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Figure 1. Mel18 Only Occupies Canonical PRC1 Sites and Is Essential for cPRC1 Stability and Gene Repression Maintenance
(A) ChIP-seq heat maps of Mel18, Ring1B, Cbx7, H2AK119ub, and IgG. Target genes were defined by the presence of one or more Mel18 peaks within ±2.5 Kb of
a given transcriptional start site (TSS).
(B) Normalized signal relative to all TSSs of Mel18, Ring1B, Cbx7, H2AK119ub, and IgG ChIP-seq.
(C) Genome-browser screenshots of the profiles of all cPRC1 components in the HOXA cluster.
(D) Endogenous coIP, using Ring1B and IgG antibodies, in control and Mel18-depleted ESCs.
(legend continued on next page)
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Figure 2. Embryoid Bodies Derived from Mel18-Depleted ESCs Cannot Differentiate Toward CMs
(A) Embryoid bodies (EBs) derived from Mel18-depleted ESCs show abnormal differentiation at day 12. Images were taken at 203magnification at days 2, 4, 6,
10, and 12 and also at 503 at day 12.
(B) Real-time qPCR of selected genes in ESCs and at day 12 of EB differentiation. Genes related to CM differentiation (Tbx5, Tbx20, Nkx2-5, Myl7, Gata4, and
Mixl1) were strongly downregulated in Mel18-depleted derived EBs. Expression was normalized to the housekeeping gene RPO. Data represent the average of
three experiments.
(C) Semiquantitative assay to analyze beating EBs. At day 5, the control and Mel18-depleted EBs were attached to the plate, and beating clusters that appeared
were counted from day 8 until day 12. Data represent the average of three experiments.
(D) Real-time qPCR of CM-specific genes in ESCs and in attached EBs at day 12 of differentiation. Expression was normalized to the housekeeping gene RPO.
Data represent the average of three experiments.
See also Figure S2.downregulated in both control and shMel18 12-day-old EBs, we
found striking differences in the expression of mesoderm/car-
diac markers (Figure 2B).
To have a better readout of the cardiac differentiation potential
of the shMel18 ESCs, wemodified the EB differentiation protocol(E) ChIP-qPCR of PcG target genes in control and in two different Mel18 KD ESC
percentage of input immunoprecipitated. All ChIP experiments represent the ave
(F) Genes deregulated by at least 2-fold and with a FPKM value > 0.1, following
(G) For Mel18 target genes deregulated after Mel18 depletion, 95.4% of upregul
(H) GO analysis of Mel18 target genes upregulated after Mel18 depletion.
See also Figure S1.
Cell Sto allow quantification of beating EBs (Figure 2C). At day 11, all
control EBs were beating, while only 20%–30% of shMel18
EBs contained beating clusters (Figure 2C). Analysis of car-
diac-specific genes confirmed that shMel18 EBs do not properly
differentiate into beating CMs (Figure 2D).s, performed with the antibodies indicated below. Results are presented as a
rage of at least three experiments.
Mel18 depletion in ESCs or in Ring1B KO ESCs.
ated genes are also Ring1B targets.
tem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Inc. 303
As Phc1 protein stability is greatly impaired in shMel18 ESCs,
we next tested whether the observed differentiation defects
were due to Phc1 depletion. CoIP experiments using a Ring1B
antibody indicated that Ring1B and Mel18 strongly interacted,
regardless of Phc1, but thatMel18 levels were slightly decreased
and the Cbx7 interaction was strongly reduced in Phc1 KD cells
(Figure S2B). shPhc1 ESCs also de-repressed Polycomb target
genes (Figure S2C), and importantly, depletion of Phc1 did not
affect the cardiac differentiation of ESCs (Figure S2D). Thus,
we conclude that the CM differentiation defect observed in
Mel18 KD cells was not Phc1 dependent.
Mel18 Is Essential for ESCs to Differentiate into Early
MES Cells
Because EB formation stimulates a chaotic ESC differentiation, it
was difficult to estimate whether the observed differentiation de-
fects were specific for the mesoderm lineage or rather were due
to secondary differentiation defects. To overcome this, we used
a protocol for differentiating ESCs into a highly homogenous
population of beating CMs (Kattman et al., 2011). Further,
because early steps of cardiac differentiation, such as formation
of early MES cells and cardiac precursor (CP) cells, can be
studied in this protocol, we asked whether Mel18 is required
for direct CM differentiation and, if so, at which stage of cardiac
differentiation Mel18 function is required (Figure 3A).
Mel18-depleted ESCs formed EB-containing MES cells (as
determined by the co-expression of the surface markers Flk1
[Kdr] and the Pdgfa receptor [Kattman et al., 2011]); however,
these were not as round and smooth as those formed from con-
trol MES EBs (Figure 3B). In our experiments, 0.1 ng/ml and
0.2 ng/ml of BMP4 generated around 60% and 70%–80% of
Flk1+ and Pdgfa+ cells, respectively (Figure 3C). Remarkably,
FACS analysis for these surface markers revealed that only
10% of Mel18-depleted cells are Flk1+/Pdgfa+. Importantly, we
did not observed accumulation of an Flk1+/Pdgfa– (hematopoiet-
ic subpopulation) or a Flk1–/Pdgfa+ population in shMel18 MES
cells, suggesting that Mel18 is essential specifically for gener-
ating MES cells and committing them to the CM lineage.
To explore the molecular mechanisms behind the Mel18-
dependent generation of MES cells, we performed global gene
expression experiments in control and Mel18-depleted MES
cells (Table S1). To control for the differentiation method, we first
analyzed genes that were up- or downregulated by at least
5-fold from control ESCs and MES cells (with FPKM R 1 in
ESCs and MES cells). We found 489 genes upregulated and
1,311genesdownregulated inMEScells (Figure3D).Asexpected,
upregulated genesweremainly associatedwithmesodermdiffer-
entiation and genes related to pathways essential for MES differ-
entiation (e.g., BMP, FGF/Brachyury, andWnt). In contrast, down-
regulatedgenesweremainlyclassifiedasESCgenes (FigureS3A).
We then analyzed the gene expression changes, using a 2-fold
cut-off, in Mel18-depleted MES cells as compared to control
MES cells. We found 421 genes to be aberrantly upregulated
in Mel18-depleted MES cells. These genes are involved in ecto-
derm differentiation and ESC pluripotency, suggesting that
Mel18 KD MES cells have lost their cell identity and are not
able to fully differentiate (Figure S3B). In contrast, the 445 down-
regulated genes were involved in mesoderm CM differentiation,
with a strong impairment of the gene networks associated with304 Cell Stem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Iearly mesoderm differentiation (Figure S3C). Similar gene cate-
gories were also observed when changes in gene expression
upon Mel18 depletion were analyzed using a 5-fold cut-off
(data not shown).
Comparing the expression of the upregulated genes in ESCs
from control MES cells with the deregulated genes in shMel18
MES cells revealed that almost 50% of the upregulated genes
in control MES cells (199 out of 489 genes) were downregulated
by at least 2-fold in shMel18 MES cells (Figure 3D). These genes
are mainly classified as mesoderm genes and, more specifically,
are involved in cardiovascular system development (Figure 3E).
Almost 10% (150 of 1,311) of the genes downregulated during
MES differentiation were aberrantly upregulated in Mel18-
depleted MES cells; interestingly, these genes were mainly
involved in ESC pluripotency (Figure 3E). Real-time qPCR anal-
ysis confirmed the reduced expression of MES-specific genes
inMel18-depletedMEScells (Figure 3F). T/Brachyury expression
was not affected in shMel18 MES cells, while Mesp1 expression
(which is downstreamof T/Brachyury duringmesodermdevelop-
ment; David et al., 2011; Herrmann et al., 1990; Saga et al., 1999)
was strongly downregulated. Thus, Mel18 is not essential for the
initialmesodermcell determination but is an essential regulator of
the MES-specific gene signature, as its depletion resulted in a
block of differentiation of early MES cells.
PRC1 Complex Composition and Genome-wide Binding
in MES Cells
We next analyzed the composition and the genome-wide distri-
bution of PRC1 in MES cells. We first determined that Mel18 in-
teracts with Ring1B in MES cells (Figure 4A) and measured the
expression levels of all cPRC1 and ncPRC1 subunits (Figure 4B).
Cbx7 and Phc1 were strongly downregulated in MES cells, with
Cbx2 and Phc2 the main Cbx and Phc family members ex-
pressed in these cells. Mel18 and Pcgf6 were the strongest
Pcgf proteins expressed in MES cells (Figure 4B). Strikingly,
while global H2AK119ub levels were constant in ESCs as
compared to MES cells, H3K27me3 levels were reduced,
concomitantwith an accumulation ofH3K27ac levels (Figure 4C).
Concordant with the effects of Mel18 depletion in ESCs, the
levels of H2AK119ub and H3K27me3 also remained unaltered
in shMel18 MES cells (Figure S4A). Western blot analysis of
several PRC1 subunits confirmed that Cbx2 and Phc2 were
strongly upregulated and that Mel18 was marginally downregu-
lated in MES cells (Figure 4D). Upon Mel18 depletion, Cbx2 pro-
tein levels were strongly impaired, yet Rybp, Ring1B, and Cbx6
remained unaffected (Figure 4D). These data suggested that a
new cPRC1 complex containing Cbx2 and Phc2 was assembled
in MES cells and that Mel18 was required to stabilize cPRC1, but
not (as in ESCs) ncPRC1.
To study the architecture of the PRC1 complex in ESCs and
MES cells, we generated an ESC line that expressed endoge-
nous levels of a Flag-Avi-tagged Ring1B (Figure 4E). Mass spec-
trometry (MS) analysis confirmed that Ring1B was associated
with at least three different known complexes in ESCs: the
cPRC1, ncPRC1, and E2F6-PRC1 complexes (Morey et al.,
2012; O’Loghlen et al., 2012; Qin et al., 2012; Tavares et al.,
2012; Wu et al., 2013; Farcas et al., 2012; He et al., 2013) (Fig-
ure S4B). In MES cells, Ring1B strongly associated with Mel18,
Pcgf6, Rybp, Cbx2, and Phc2. Interestingly, we only foundnc.
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Figure 3. Mel18-Depleted ESCs Do Not Properly Differentiate into Early MES Cells
(A) Schematic representation of the protocol used to differentiate ESCs to CMs (Kattman et al., 2011).
(B) Representative pictures of control and Mel18-depleted MES cells. Images were taken at 203 magnification.
(C) FACS analysis using FLK1 and Pdgfa antibodies in control and Mel18-depleted MES cells induced by two different concentrations of BMP4.
(D) RNA-seq heat map of up- and downregulated genes in control or Mel18-depleted MES cells as compared to control ESCs. Only genes up- or downregulated
at least 5-fold from ESCs are shown.
(E) GO analysis of genes deregulated by at least 2-fold in Mel18-depleted MES cells as compared to control MES cells.
(F) Real-time qPCRof specificMES genes in control orMel18-depletedMES cells. Expressionwas normalized to the housekeeping geneRPO. Data represent the
average of six experiments.
See also Figure S3.Pcgf6 as a core subunit of the E2F6-PRC1 complex, suggesting
that this complexmight not be involved in ESCdifferentiation into
MES cells (Figure 4F).We next analyzed a time course of ESC-to-
MES cell differentiation to determine the time frame in which the
switch of the cPRC1 complex composition occurs. Changes in
protein levels of PRC1 subunits seemed to be cytokine depen-
dent, sincemajor protein changes occurred 24 hr post-induction
(Figure S4C). In agreement with reduced levels of H3K27me3 inCell SMES cells, Ezh2 was strongly downregulated during ESC differ-
entiation (Figure S4C). We did not observe changes in Ezh1
expression at these differentiation stages (Table S1).
We next performed ChIP-seq experiments of Ring1B, Mel18,
Rybp, and Cbx2 in MES cells (Table S1). As expected, Mel18,
Ring1B, and Rybp occupied genes not previously occupied
by PRC1 in ESCs and were displaced from genes previously
occupied in ESCs, indicating a partial re-localization of PRC1tem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Inc. 305
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Figure 4. PRC1 Composition, Genome-wide Occupancy, and Expression of Polycomb Target Genes in MES Cells
(A) Endogenous coIP, using a Ring1B and IgG antibodies from MES cells.
(B) RNA-seq expression of PRC1 subunits in MES cells represented by FPKM values.
(legend continued on next page)
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genome binding in differentiating cells (Figure 4G). Surprisingly,
de novo Ring1B target genes in MES cells were mainly associ-
ated with metabolic processes (Figure S4D). Cbx7 binding
is substituted for Cbx2 in 1,589 genes previously bound by
Cbx7 in ESCs (Morey et al., 2012), and Cbx2 binds to 1,382
MES-specific genes (Figure 4G and Figures S4E and S4F).
Cbx7 ESC genes and common Cbx7/Cbx2 target genes in
ESC/MES cells were related to development, yet Cbx2 MES
cell targets were also strongly associated with metabolic pro-
cesses (Figure S4E).
Detailed analyses of Ring1B, Mel18, Rybp, and Cbx2 target
genes disclosed at least six different types of genes robustly
bound by different combinations of PRC1 subunits. A genome
browser screenshot of a large region of chromosome 1 shows
genes co-bound by all four PRC1 subunits (#1), by Ring1B either
alone (#2) or with Rybp (#3), or by Mel18 and Rybp, but not Cbx2
(#4) (Figure 4H). We also found Rybp bound to 1,058 genes that
contained no traces of any PRC1 subunit (Morey et al., 2013) and
genes with Mel18, Ring1B, and Cbx2 without Rybp (Figure 4I).
The 2,186 genes co-bound by Ring1B, Mel18, Cbx2, and
Rybp (Figure 4I) were classified as developmental genes and,
more specifically, as ectoderm andmesoderm genes (Figure 4J).
We also found examples of genes that were co-bound by all four
PRC1 members involved in cardiac differentiation (Bruneau,
2013), endoderm differentiation, and pluripotency/ectoderm
(Figures S4G and S4H).
Hypothesizing that genes bound by different combinations of
PRC1 subunits might be expressed differently, we intersected
our RNA-seq of control MES cells with the different ChIP-seq
datasets and with an H3K27me3 dataset (Wamstad et al.,
2012). Indeed, Ring1B andRybp target genes that do not contain
Mel18, Cbx2, and/or H3K27me3 were expressed at higher levels
than genes containing all PRC1 members and PRC2 (Figure 4K).
Moreover, genes containing Cbx2, but not Rybp (class 5 versus
class 6), were also more repressed than the genes containing
Rybp, but not Cbx2 (Morey et al., 2013) (Figure 4K). GO analysis
of the six gene classes indicated that different genes containing
particular combinations of PRC1 subunits have specific biolog-
ical functions (Table S1).
To substantiate the observation that Polycomb-containing
genes are transcriptionally active, we looked for H3K36me3 his-
tone modifications (Wamstad et al., 2012). Almost all genes from
the classes 2, 3, and 4 contained H3K36me3, thus confirming
that they are active (Figure 4L; Figure S4I) and suggesting that
recruitment of Ring1B or Rybp per se was not enough to repress
transcription. We thus hypothesized that they might function as(C) Western blots of histone modifications analyzed from acid-extracted histone
(D) Western blots of PRC1 subunits from control or shMel18 ESCs or from MES
(E) Western blots of Ring1B and streptavidin in control BirA ESCs or BirA ESCs
(F) Purification protocol and MS analyses of PRC1 subunits associated to Ring1
(G) Venn diagram of Ring1B, Mel18, Cbx2, and Rybp target genes in MES cells.
(H) Genome browser screenshots of Ring1B, Mel18, Cbx2, and RYBP ChIP-seq
bound by specific PRC1 members.
(I) Venn diagram of Ring1B, Mel18, Cbx2, and Rybp target genes in MES cells.
(J) GO analysis of the 2,186 genes co-bound by Ring1B, Mel18, Cbx2, and Rybp
(K) Expression of six different classes of genes bound by Ring1B, Mel18, Cbx2,
(L) Number of class 1, 2, and 4 genes that contain H3K36me3.
(M) GO analysis of the 647 genes co-bound by Ring1B, Mel18, Cbx2, and Rybp
See also Figure S4.
Cell Sco-activators. Interestingly,wealsoobserved thataboutone-third
of class 1 genes also contained H3K36me3 (Figure 4L; Table S1).
GO analysis revealed that these genes were mainly associated
with cell-cell adhesion and heart development (Figure 4M).Genes
within this category are strongly related to the BMP pathway and
the transcription factors indispensable for early heart develop-
ment (Table S1). Genes containing H3K36me3 from the six clas-
ses have different biological functions (Figure S4J), suggesting
that genes containing different combinations of PRC1 members
and histone modifications regulate distinct cellular pathways
and processes. Overall, these data demonstrate that a new
cPRC1 complex was assembled in MES cells and that cPRC1
and ncPRC1 complexes bind to more than 2,000 genes in these
cells, yet different gene classes can contain distinct combinations
of Polycomb subunits. Strikingly, binding of Polycomb proteins
was not always associated with gene repression.
Mel18 Directly Regulates Expression of MES-Specific
Genes
We hypothesized that the Mel18-mediated phenotype in MES
cells might be connected with the direct regulation of genes en-
coding transcription factors directing cardiac differentiation.
Since the set of 647 class 1 active genes contained Mel18 (see
Figure 4L), we investigated whether Mel18 is also involved in
gene transcription.
Compared to their wild-type counterparts, Mel18-depleted
MES cells aberrantly deregulated a very similar number of genes,
with an altered expression of more than 300 Mel18 targets (Fig-
ure 5A). A higher number of Mel18 targets were downregulated
(201) than upregulated (116) (Figure 5A). The downregulated
201 genes were expressed and contained H3K36me3 in wild-
type cells, suggesting again that Mel18 might be required for
proper gene transcription of these genes. To confirm that
Mel18 was bound to H3K36me3-containing genes, we per-
formed a sequential Mel18/H3K36me3 ChIP assay (Figure 5B).
GO analysis revealed that the Mel18 targets downregulated
upon its depletion were mainly related to mesoderm specifica-
tion, whereas the upregulated genes were associated with regu-
lation of the other cell linages and stem cells (Figure 5C).
To strengthen the observation that Mel18 might control
expression of active genes in MES cells, we selected the
highest-induced genes from ESC-to-MES differentiation, which
were upregulated by at least 25-fold (FC25) and had an
FPKM R 1 in MES cells (Table S1). Analysis of Mel18, Ring1B,
Cbx2, and Rybp ChIP-seq signal at these 98 genes clearly
showed a positive signal over the IgG ChIP-seq (Figure 5D).s.
cells.
that expressed Ring1B.
B in MES cells.
assays performed in MES cells. Boxes represent different classes of genes
.
Rybp, and/or H3K27me3.
that contain H3K27me3 and H3K36me3 histone modifications.
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While not all 98 genes contained a PRC1 subunit, 24 were bound
by all four subunits (Figure S5A). Further, Rybp was present in
more genes than Cbx2, reinforcing the concept that genes con-
taining Rybp, rather than just any Cbx protein, are more ex-
pressed (Figure S5A). Genome-browser screenshots of the
Ring1B, Mel18, Rybp, and Cbx2 ChIP-seq signal at some of
the FC25 genes (Hand1, Lhx1, and Six2) and Gata4 are shown
in Figure 5E. We then assessed whether these promoters, which
were highly expressed yet contained PRC1 complexes, also
contained H3K27me3. These four promoters (and in general,
all the FC25 genes) were decorated not only with H3K4me3
and H3K36me3, but also with H3K27me3 (Figure 5E; Fig-
ure S5B). Interestingly, the H3K4me3 profiles for the Hand1,
Lhx1, and Six2 loci were not restricted to the transcriptional start
site (TSS), but rather, they resembled the broad H3K4me3 do-
mains present in genes that define cell identity (Benayoun
et al., 2014). ChIP-qPCR assays confirmed that Ring1B, Rybp,
and Mel18 co-bound to the promoter of these four genes (Fig-
ures S5C and S5D). Similar to ESCs, Mel18 was required in
MES cells for full Ring1B binding and H2AK119ub and
H3K27me3 deposition, while Rybp binding remained unaltered
(Figure S5D, lower panel). Not all FC25 genes contained PRC1
subunits in MES cells; for instance, Mel18 and Ring1B bind at
high levels to T andMesp1 in ESCs but were displaced from their
promoters in MES cells (Figures S5C and S5D).
In ESCs, Cbx7 depletion reduces the chromatin binding for
Mel18, but not Rybp (Morey et al., 2013); similarly, in Cbx2-
depleted MES cells, Mel18 binding was partially reduced, while
Rybp recruitment was either not affected or even slightly
increased (Morey et al., 2012) (Figure S5E).
In addition to affecting the FC25 direct target genes, Mel18
depletion also downregulated FC25 genes that did not contain
Polycomb proteins, implying a secondary effect probably medi-
ated by the deregulation of FC25 genes bound by Mel18 (Fig-
ure 5F, right panel); see also examples for Gata4, Lhx1, Hand1,
Six2, and T expression after Mel18 depletion (Figure 5G; Table
S1). The expression of genes containing Rybp, but not Cbx2,
was less affected by Mel18 depletion, suggesting that the
Mel18 function was strongly associated with the cPRC1 com-
plex (Figure 5F, middle panel).
To establish controls, we first assured that our results were not
affected by cell heterogeneity by FACS sorting to select the
FLK1+/Pdgfa+ cell population (as differentiation of MES cells
in vitro is never 100% efficient—we routinely achieved 70%–Figure 5. PRC1 Complexes Bind to Highly Active, Early Cardiac-Meso
(A) Number of deregulated genes in shMel18 MES cells crossed with Mel18 targ
(B) Re-ChIP-qPCR performed using a Mel18 antibody or IgG. Eluted material w
sequential-ChIPwere analyzed by qPCR and are represented as a percentage of i
the average of two experiments. Sox2 and T loci were used as negative controls
(C) GO analysis of Mel18 target genes downregulated or upregulated upon Mel1
(D) Normalized Ring1B, Mel18, Cbx2, and Rybp ChIP-seq signals at genes upre
(E) Genome-browser screenshots of Ring1B, Mel18, Cbx2, Rybp, H3K27me3, H
(F) Expression of FC25 genes in ESCs and control andMel18-depletedMES cells d
Mel18, and Rybp (with no Cbx2); and FC25 genes with no PRC1 subunits.
(G) RNA-seq FPKM values of genes analyzed in (F), and T, in control and Mel18-
(H) FACS-sorting profile example in which FLK1+/Pdgfa+ cells were sorted.
(I) ChIP-qPCR of Mel18/Ring1B target genes in sorted FLK1+/Pdgfa+ cells. T and
negative control, for the Mel18, Cbx2, and H3K27me3 antibodies. All ChIP expe
See also Figure S5.
Cell S80% of FLK1+/Pdgfa+cells) (Figure 5H). We confirmed that the
Gata4, Lhx1, Hand1, and Six2 promoters, but not the T or
Mesp1 promoters, were bound by Mel18 and Cbx2 and were
decorated with H3K27me3 in FLK1+/Pdgfa+ cells (Figure 5I) and
that the expression of all six genes was very high in these cells
as compared to ESCs (Figure S5F). Second, to rule out potential
off-target shRNA effects, we generated two Mel18 knockout
(KO) ESCs lines (named 12.1 and 12.2) by CRISPR/Cas9. Similar
to the shMel18 ESCs, Phc1 protein levels were also strongly
downregulated in both KO cell lines (Figure S5G), and ChIP-
qPCR assays confirmed that Mel18 was required for full Ring1B
binding to chromatin (Figure S5H). MES-derived EBs from
Mel18 KO cells were also affected (Figure S5I). Finally, ChIP ex-
periments confirmed that Ring1B and Mel18 co-occupied the
Gata4, Lhx1, Hand1, and Six2 promoters and that Ring1B was
strongly displaced in Mel18 KO MES cells (Figure S5J).
Mel18 Directly Controls Negative Regulators of the BMP
Pathway in MES Cells
In addition to regulating genes implicated in early MES differen-
tiation (Figure 5D), Mel18 also functions as a classical Polycomb
protein (Figures 4H–4J). As the BMP pathway needs to be tightly
regulated during early mesoderm differentiation, Mel18 could
also be involved in repressing negative regulators of the pathway
to ensure its proper activation and function. Indeed, we found
that Mel18, together with Ring1B, Rybp, and Cbx2, were bound
to the promoter of four well-known negative regulators of the
BMP pathway (Ramel and Hill, 2012) (Figure 6A). ChIP-qPCR ex-
periments confirmed that Ring1B and Mel18 co-occupy these
four promoters and that Ring1B recruitment was partially depen-
dent on Mel18 (Figure 6B). Notably, Mel18 and Ring1B displace-
ment in shMel18 cells resulted in upregulation of Nbl1 and Chrd
(Figure 6C). Mechanistically, Chrd prevents BMP binding to its
receptor (Larraı´n et al., 2000), subsequently blocking the
pathway, which in turn can be reestablished when high doses
of BMP4 are delivered to the cells. Administrating 1 ng/ml of
BMP4 to shMel18 cells induced re-expression of Flk1 and
Mesp1 (Figure 6D). Moreover, the features of shMel18 MES
EBs closely resembled those of control MES EBs (Figure 6E).
Mel18 Depletion Blocks CM and Cartilage
Differentiation
We next determined whether shMel18 MES cells can terminally
differentiate into beating CMs. In accordance with our genederm-Specific Genes
et genes.
as then used for re-ChIP using an H3K36me3 or IgG antibody. Results of the
nput immunoprecipitated from theMel18 ChIP. Re-ChIP experiments represent
for the Mel18-H3K36me3 re-ChIP.
8 depletion in MES cells.
gulated at least by 25-fold (FC25) from ESCs to MES cells.
3K36me3, and H3K4me3 occupancy at three FC25 gene loci and Gata4.
ivided in genes containing Ring1B,Mel18, Cbx2, and Rybp (all PRC1); Ring1B,
depleted MES.
Mesp1 promoters were used as negative control genes, and IgG antibody as a
riments represent an average of two experiments.
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Figure 6. A Mel18-Mediated Differentiation Block of Cardiac-Mesoderm Cells Was Partially Rescued by a High BMP4 Dose
(A) Genome-browser screenshots of ChIP-seq profiles of Ring1B, Mel18, Cbx2, and Rybp in MES cells at negative regulators of the BMP pathway.
(B) ChIP-qPCR of negative regulators of the BMP pathway in control andMel18-depletedMES. All ChIP experiments represent the average of three experiments.
(C) Real-time qPCR of the same genes from (A) and (B) in control and Mel18-depleted MES cells.
(D) Real-time qPCR of MES-specific genes in control and Mel18-depleted MES cells induced with two BMP4 concentrations. Expression was normalized to the
housekeeping gene RPO. Data represent the average of three experiments.
(E) Representative pictures of control MES cells and Mel18-depleted MES cells induced to differentiate with a higher BMP4 dose. Images were taken at
20 3 magnification.expression profiles, T protein levels were unaffected in Mel18-
depleted cells during the course of ESC differentiation into
MES cells, while Mesp1 protein levels were reduced, but not
completely abolished (Figure 7A). Mechanistically, both T and
Mesp1 promoters showed reduced levels of Ring1B and Mel18
after induction of MES differentiation (Figure S6A). To generate
CM precursors and beating CMs, the EBs containing the MES
cells needed to be disaggregated and plated in monolayer (Fig-
ure 3A). Disaggregated shMel18 MES cells attached to the
plate as the wild-type and could be maintained in cardiac
media; however, they did not grow in monolayers but rather
formed cell clumps (Figure 7B). Strikingly, very few shMel18
cells were capable of beating (Movie S1 and Movie S2). We
observed that two contraction-associated proteins, cTnT (car-
diac troponin T) and a-actinin, were strongly reduced in Mel18-
depleted CMs (Figure 7C). To evaluate whether these cells
remained undifferentiated or if Mel18 depletion resulted in cell
fate changes, we performed RNA-seq experiments. Around
1,500 genes were deregulated by at least 2-fold, and around
700 genes were deregulated by at least 3-fold, in Mel18-
depleted CMs as compared to control CMs (Figure 7D). In310 Cell Stem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Icontrast to shMel18 MES cells, more genes were upregulated
in shMel18 CMs using both cut-offs (Figures 5A and 7D). Impor-
tantly, downregulated genes weremainly involved in heart devel-
opment and function, and these were also Polycomb target
genes in the heart (Figure 7E; Figure S6B). Upregulated genes
were strongly related to ESC genes and specifically, to different
cardiomyopathies (Figure 7F; Figure S6C). GO analysis of the de-
regulated genes using a 5-fold cut-off revealed the same gene
categories as observed when a 2-fold cut-off was applied
(data not shown).
To better understand the function of the deregulated genes in
shMel18 CMs, we first analyzed the ESC, MES, and CM gene
signatures. We defined the characteristic gene signature of
each cell type (ESC, MES, and CM) as the set of genes ex-
pressed (FPKM R 1) that are at least 5-fold upregulated as
compared to the other cell types (Figure 7G). Analysis of genes
deregulated by at least 2-fold in Mel18-depleted CMs compared
to CM-specific genes revealed that 218 genes were down-
regulated, while 171 ESC-specific genes were upregulated (Fig-
ure 7G). In agreement with the previous analysis, downregulated
genes were associated with ESCs (Figure S6D), and upregulatednc.
genes, to muscle system, heart development, and cardiac-asso-
ciated diseases (Figure S6E).
Real-time qPCR analysis of CM-specific proteins and tran-
scription factors confirmed that cells lacking Mel18 did not
properly differentiate into functional CMs (Figure 7H). We also
performed the full cardiac differentiation assay using wild-type
and Mel18 KO ESCs as a control. Indeed, Mel18 KO cells also
failed to express several CM genes (Figure S6F), and FACS anal-
ysis using a cTnT antibody confirmed that the population of
beating CMs was greatly reduced in these cells (Figure S6G).
In Mel18-depleted CMs, ESC markers were strongly upregu-
lated, and cardiac markers, downregulated, while chondrocyte,
neuroectoderm, endoderm, and hematopoietic genes were not
expressed, confirming that shMel18 CM cells did not change
their cell fate and are ultimately non-differentiated cells with a
ESC-like gene expression profile (Figure S6H; Table S1). Finally,
we asked whether PRC1 subunits were differentially expressed
in control CMs as compared to ESCs and MES cells. Cbx4,
Phc3, and Pcgf5 were upregulated in CM cells, suggesting that
alternative PRC1 complexes might exist in these cells (Figures
S6I and S6J).
BecauseMel18 KOmice do not display evident defects in heart
development, andasPcgf5 is upregulated inCMcells,wehypoth-
esized that Pcgf5might be also involved in CMdifferentiation.We
depleted Pcgf5 fromESCs (Figure S7A) and then submitted these
ESCs to EB differentiation (as for Figure 2C). shPcgf5 ESCs ex-
pressed normal levels of pluripotent markers and could be main-
tained in culture (Figure S7B).We observed that shPcgf5 EBs had
adelay in their beatingcapacity, yet theeffectwasnot asstrongas
that observed for shMel18 ESCs (Figures S7C–S7D). These data
suggest that Pcgf5 is also involved in cardiac differentiation
in vitro. We then generated ESCs depleted for Mel18 and Pcgf5
to assess whether a Pcgf5 KD would have an additive effect on
cells depleted for Mel18. Mel18/Pcgf5 KD ESCs can also be
cultured and express normal pluripotency genes (Figures S7E–
S7G), and levels of PRC1 members are similar to the shMel18-
ESCs (Figure S7H). Real-time qPCR analysis of control, shMel18,
double KD (dKD) control cells, and Mel18/Pcgf5 dKD 12-day-old
EBs indicated that Pcgf5 cooperates with Mel18 during cardiac
differentiation (Figures S7I and S7J).
Finally, we examined whether the Mel18 function during differ-
entiation is restricted to cardiac cells or whether it is also neces-
sary for differentiation of ESCs into other mesoderm-derived
cells or cells derived from other cell lineages in vitro. We differen-
tiated control and Mel18-depleted ESCs into cartilage cells
(Craft et al., 2013) (Figure 7I) and NPCs. Mel18-depleted cells
were not capable of fully differentiating into cartilage cells (Fig-
ures 7J and 7K), but efficiently differentiated into NPCs (Figures
S7K–S7M). RNA-seq experiments in control and shMel18-
derived NPCs indicated that around 200 and 70 genes were
up- or downregulated by at least 2- or 3-fold, respectively, in
Mel18-depleted cells. Analyzing the ESC and NPC gene signa-
tures, we found that only 57 genes were downregulated, while
70 ESC-specific genes were upregulated (Figure S7O). GO anal-
ysis of these sets of genes did not show significant association to
any biological process (Figure S7O). We therefore conclude that
Mel18 specifically controls ESC differentiation toward meso-
derm-derived cells, but not toward other cell linages, such as
neuroectoderm precursors.Cell SDISCUSSION
Here we propose Mel18 as a new epigenetic factor that
specifically controls mesoderm differentiation by at least two
opposite mechanisms. While Mel18 functions as a classical
Polycomb gene in pluripotent cells, it is associated with a
PRC1 complex that functions as both a repressor and an
activator during early cardiac mesoderm cell differentiation
(Figure 7L). We propose that Mel18 directly controls the
activity of genes encoding transcription factors essential for
early cardiac mesoderm cell specification yet also directly
controls the expression of the negative regulators of the
BMP pathway and genes involved in late cardiac differentia-
tion, pluripotency, and ectoderm and endoderm cell fate to
ensure their transcriptional repression in the early steps of
cardiac differentiation.
Mutant Mel18 mice have an apparently normal heart (yet die
shortly after birth, so it is not clear how long this heart is func-
tional). How can we explain this apparent inconsistency with
our observation that Mel18 is an essential epigenetic factor
implicated in CM differentiation in vitro? Inherent differences be-
tween in vitro and in vivo environments, such as local fluxes
in vivo that could compensate for differentiation challenges,
could be partially responsible. For instance, we observed
in vitro that increasing BMP4 rescued the differentiation defects
of the Mel18 mutant cells, and local variations in BMP signaling
occur in vivo, during, for example, gastrulation. Additionally,
another Pcgf protein could compensate for the lack of Mel18
during heart development in vivo. One candidate could be
Pcgf5, which we found to be strongly upregulated during late
CM differentiation in vitro, and the depletion of which delayed
CM differentiation. Further studies using mice with a conditional
Mel18 mutant in the heart or with a double Mel18/Pcgf5 mutant
will shed light about the in vivo contributions of Mel18 and
other Pcgf proteins during heart development and homeostasis
of the tissue. Finally, deregulated genes in Mel18-depleted
CMs are related to cardiomyopathies. None of the genes previ-
ously reported to be mutated in cardiomyopathies were deregu-
lated in Mel18-depleted CMs, suggesting that either Mel18 is a
gene newly associated with heart abnormalities, or that Mel18
controls molecular pathways deregulated in heart diseases.
Further analyses at both the genetic and molecular levels are
required to determine the possible role of PRC1 proteins in heart
diseases.
Our functional and genome-wide studies suggest that Mel18
directly controls several pathways important for CM differentia-
tion in vitro. Mel18 positively regulates expression of essential
transcription factors involved in early cardiac differentiation,
suggesting a function of a Polycomb protein as a co-activator.
One possibility could be that that expression of highly active
genes containing cPRC1, ncPRC1, and PRC2 complexes is
regulated by ncRNAs (such as enhancer RNAs) that cooperate
with positive transcription regulators. Another characteristic of
the MES-specific highly active genes containing Polycomb
complexes was the presence of a specific breadth of the
H3K4me3 domain and a particular deposition pattern of
H3K36me3. Interestingly, the breadth of broad H3K4me3 do-
mains has been recently linked to transcriptional consistency
at genes essential for cell identity (Benayoun et al., 2014).tem Cell 17, 300–315, September 3, 2015 ª2015 Elsevier Inc. 311
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Detailed analyses of these multivalent regions warrant further
investigation.
It has been recently proposed that a PRC1 variant containing
AUST2 and a phosphorylated form of Ring1B, but no Cbx pro-
teins, binds to active genes in neurons (Gao et al., 2014). There-
fore, another possibility could be that the PRC1 complexes that
regulate gene activity in MES cells also contain a post-transcrip-
tionally modified Ring1B (or other subunit). Due to the lack of
specific antibodies against the CK2-mediated Ring1B phos-
phorylated form, we could not assess whether this is the case
in our cellular system.
Could post-transcriptional modifications of Polycomb pro-
teins be involved in tuning the enzymatic activity of the
Polycomb complexes? We suggest that specific PRC1 com-
plexes (Figure 7M) might cooperate with specific molecules,
in different cell types and biological process, to regulate and
modulate Polycomb activities. Additionally, the involvement
of Mel18 in CM differentiation makes it also worth investiga-
ting whether any disturbances in this mechanism underlie
cardiomyopathies.
EXPERIMENTAL PROCEDURES
Generation of Stable ESC KD Cultures
ESCs expressing stable pLKO-shRNA (Sigma) vectors against Mel18, Phc1,
and Pcgf5 mRNAs were generated as previously described (Morey et al.,
2013). To generate Mel18/Pcgf5 dKD cells (dKD ESCs), shMel18 ESCs were
transduced with lentiviruses expressing a shPcgf5-Hygromycin vector. We
also transduced the shCTR-ESCs with a pLKO-Hygromycin-control vector
to generate ESCs resistant to puromycin and hygromycin (dKD control ESCs).
ChIP and Re-ChIP Assays
ChIP and re-ChIP experiments in ESCs were performed as previously
described (Morey et al., 2013). ChIP assays in MES cells were performed
with the following modifications: MES cells were centrifuged 3 min at
800 rpm to discard cells that did not form EBs. EBs were trypsinized with
TrypLE Express and then crosslinked, lysated, and sonicated as described
for ESC ChIPs. Antibodies and primers used for ChIP-qPCR are given in
Table S1.
Differentiation Assays
ESCs were differentiated into EBs and NPCs as previously described (Aloia
et al., 2014; Morey et al., 2012). CMs and cartilage differentiation assaysFigure 7. Generation of CMs and Cartilage Cells Was Impaired in Cells
(A) Western blot of T and Mesp1 in ESCs and during their differentiation to MES
(B) Representative pictures of control CM and the resulting Mel18-depleted cells
(C) Western blot of a-actinin and cTnT at day 10 of CM differentiation in control
(D) Deregulated genes in Mel18-depleted CM.
(E and F) GO analysis of genes downregulated (E) and upregulated (F) by at leas
(G) Heat map of ESCs, MES, and CM-specific genes and genes deregulated in s
(H) Real-time qPCR of Mel18 and CM-specific genes in control and Mel18-de
experiments.
(I) Schematic representation of the protocol used to differentiate ESCs to cartilag
(J) Representative pictures of control Mel18-depleted cells at day 14 of different
(K) Real-time qPCR of cartilage-specific genes in control and Mel18-depleted cel
(L) Proposed model for Mel18 function during cardiac differentiation. In ESCs, c
induced to differentiate into early MES cells, a new cPRC1 complex is assembled
expression of mesoderm transcription factors and negatively regulates pluripo
regulators of the BMP pathway. Mel18 depletion results in a disassembly of the
ripotency genes, ectoderm genes, and negative BMP regulators. Reduced expre
differentiation.
(M) PRC1 complexes are characterized by the presence of Cbx, Pcgf, and Ryb
Polycomb complexes are assembled, thereby allowing a higher level of fine-tuni
Cell Swere performed as previously described (Craft et al., 2013; Kattman et al.,
2011) with the following modifications. In our hands, generation of a highly en-
riched population of MES cells was strongly influenced both by the dose and
the batch of BMP4. Typically, we obtained the best differentiation results with
0.1–0.3 ng/ml of BMP4. We also noticed that the amount of MES cells seeded
to obtain cardiac precursor cells was crucial to obtain a high percentage of
beating CMs, with the best results obtained when 125,000–150,000 MES cells
were seeded in a 96-well plate. For cartilage differentiation, we also titrated the
amount of BMP4 and the number of cells; we obtained the best differentiation
using 5 ng/ml of BMP4 and seeding 3,000 cells in a 96-well plate.
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